Novartis Investigative Site

San Salvador de Jujuy, Jujuy Province Y4600ABF

0 studies enrolling now · 6 studies all time

What they study most

Acute Heart Failure, Advanced Metastatic Breast Cancer, Atherosclerosis, Chronic Heart Failure With Reduced Ejection Fraction, Early Breast Cancer, Heart Failure With Reduced Ejection Fraction

Studies at this site

• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling
• Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction — Completed
• Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early